1
|
Moorthy NHN, Singh M, Chandraker V, Karthikeyan C. Anti-colorectal Cancer Activity of Quinazoline Derivatives: A Comprehensive Review. LETT DRUG DES DISCOV 2023. [DOI: 10.2174/1570180820666230310112000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/12/2023]
Abstract
Introduction and Objective:
The identification of a bioactive template (or lead) is one of the important features of modern drug discovery. Natural products, synthetic and biotechnological sources, serve as important templates for the development of novel bioactive molecules. Quinazoline is one of the heterocyclic templates present in many natural and synthetic drugs and exhibits various biological activities, including anticancer, by blocking the pharmacological pathway of different targets.
Methodology:
This study collected data from the literature and patents to examine the anti-colorectal cancer efficacy of quinazoline compounds and their action mechanisms. According to the published literature and patents, the benzene and/or pyrimidine rings of the quinazoline have been substituted with amino groups or substituted amino groups to develop novel analogues endowed with anticancer properties. The anti-colorectal cancer activity of quinazolines was due to the flexible chain containing terminal phenyl and/or heterocyclic rings (thiazole, pyrazole, piperidine, piperazine, etc.).
Results:
These quinazoline derivatives were found to inhibit the growth of colorectal cancer cells by modulating the expression of specific genes and proteins involved in cancer progression, such as receptor tyrosine kinases, epidermal growth factor receptors, dihydrofolate reductase, topoisomerases, histone deacetylase, and apoptotic proteins.
Conclusion:
These findings suggest that the quinazoline nucleus may be exploited to identify new anti-colorectal cancer agents with suitable pharmacokinetic profiles.
Collapse
Affiliation(s)
- N.S. Hari Narayana Moorthy
- Cancept Therapeutics Laboratory, Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak- 484887, Madhya Pradesh, India
| | - Madan Singh
- Cancept Therapeutics Laboratory, Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak- 484887, Madhya Pradesh, India
| | - Vivek Chandraker
- Cancept Therapeutics Laboratory, Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak- 484887, Madhya Pradesh, India
| | - C. Karthikeyan
- Cancept Therapeutics Laboratory, Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak- 484887, Madhya Pradesh, India
| |
Collapse
|
2
|
Patel J, Maiti S, Moorthy NHN. Repaglinide-laden hydrogel particles of xanthan gum derivatives for the management of diabetes. Carbohydr Polym 2022; 287:119354. [DOI: 10.1016/j.carbpol.2022.119354] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 02/25/2022] [Accepted: 03/10/2022] [Indexed: 11/02/2022]
|
3
|
Maheshwari N, Karthikeyan C, Bhadada SV, Verma AK, Sahi C, Moorthy NHN, Trivedi P. Virtual Screening Based Discovery of PTP1B Inhibitors and Their Biological Evaluations. LETT DRUG DES DISCOV 2021. [DOI: 10.2174/1570180817999200826174051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background :
The discovery of novel antidiabetics for the treatment of type 2 diabetes
mellitus (T2DM) is an important task nowadays because the current treatment approaches have certain
limitations. The reported studies showed that the protein tyrosine phosphatase 1B (PTP1B) is a
valuable target, can be used to develop significant antidiabetic molecules.
Objective:
In the present investigation, computational methods and biological evaluation studies have
been applied to develop novel PTP1B inhibitors with good enzyme binding affinity and activity.
Methods:
Virtual screening (docking) analysis of SPECS database compounds on PTP1B enzyme
was performed using Schrodinger software. In vitro and in vivo biological evaluations had been
conducted with the identified hits.
Results:
The results revealed that the molecules identified through these studies have shown significant
interactions with the active site residues of the PTP1B enzyme. The compounds S1 and S2 provided
significant binding interactions with the residues (Arg221 and Gln262) and have shown considerable
in vitro PTP1B inhibitory activity and in vivo antidiabetic activity. The compounds S1 and
S2 possessed 35.44±0.12% and 33.68±0.08% inhibitory activities, respectively.
Conclusion:
These identified hits will be used as a template for design and development of novel
PTP1B inhibitors with a compatible pharmacokinetic profile.
Collapse
Affiliation(s)
- Neelesh Maheshwari
- School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal (MP)-462036, India
| | - Chandrabose Karthikeyan
- School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal (MP)-462036, India
| | - Shraddha V. Bhadada
- Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India
| | - Amit K. Verma
- Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh 462066, India
| | - Chandan Sahi
- Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh 462066, India
| | - N.S. Hari Narayana Moorthy
- School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal (MP)-462036, India
| | - Piyush Trivedi
- School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal (MP)-462036, India
| |
Collapse
|
4
|
Maheshwari N, Karthikeyan C, Bhadada SV, Verma AK, Sahi C, Moorthy NHN, Trivedi P. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors. Bioorg Chem 2019; 92:103221. [DOI: 10.1016/j.bioorg.2019.103221] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 07/05/2019] [Accepted: 08/26/2019] [Indexed: 12/11/2022]
|
5
|
|
6
|
Hari Narayana Moorthy N, Vittal UB, Karthikeyan C, Thangapandian V, Venkadachallam A, Trivedi P. Synthesis, antifungal evaluation and in silico study of novel Schiff bases derived from 4-amino-5(3,5-dimethoxy-phenyl)-4H-1,2,4-triazol-3-thiol. ARAB J CHEM 2017. [DOI: 10.1016/j.arabjc.2013.12.021] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
7
|
Abstract
Influenza virus is an important RNA virus causing pandemics (Spanish Flu (1918), Asian Flu (1957), Hong Kong Flu (1968) and Swine Flu (2009)) over the last decades. Due to the spontaneous mutations of these viral proteins, currently available antiviral and anti-influenza drugs quickly develop resistance. To account this, only limited antiinfluenza drugs have been approved for the therapeutic use. These include amantadine and rimantadine (M2 proton channel blockers), zanamivir, oseltamivir and peramivir (neuraminidase inhibitors), favipravir (polymerase inhibitor) and laninamivir. This review provides an outline on the strategies to develop novel, potent chemotherapeutic agents against M2 proton channel. Primarily, the M2 proton channel blockers elicit pharmacological activity through destabilizing the helices by blocking the proton transport across the transmembrane. The biologically important compounds discovered using the scaffolds such as bisnoradmantane, noradamantane, triazine, spiroadamantane, isoxazole, amino alcohol, azaspiro, spirene, pinanamine, etc are reported to exhibit anti-influenza activity against wild or mutant type (S31N and V27A) of M2 proton channel protein. The reported studies explained that the adamantane based compounds (amantadine and rimantadine) strongly interact with His37 (through hydrogen bonding) and Ala30, Ile33 and Gly34 residues (hydrophobic interactions). The adamantane and the non-adamantane scaffolds fit perfectly in the active site pocket present in the wild type and the charged amino groups (ammonium) create positive electrostatic potential, which blocks the transport of protons across the pore. In the mutated proteins, larger or smaller binding pocket are created by small or large mutant residues, which do not allow the molecules fit in the active site. This causes the channel to be unblocked and the protons are allowed to transfer inside the pore. The structural analysis of the M2 proton channel blockers illustrated that the adamantane derivatives have action against both influenza A and B, but have no effect on the mutants.
Collapse
|
8
|
Moorthy NHN, Ramos MJ, Fernandes PA. hERG binding feature analysis of structurally diverse compounds by QSAR and fragmental analysis. RSC Adv 2011. [DOI: 10.1039/c1ra00131k] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
9
|
Karthikeyan C, Moorthy NHN, Trivedi P. QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors. J Enzyme Inhib Med Chem 2009; 24:6-13. [DOI: 10.1080/14756360701810355] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Affiliation(s)
- C. Karthikeyan
- School of Pharmaceutical Sciences, Rajiv Gandhi Technical University, Airport Bypass Road, Gandhi Nagar, Bhopal 462036, MP, India
| | - N.S. Hari Narayana Moorthy
- School of Pharmaceutical Sciences, Rajiv Gandhi Technical University, Airport Bypass Road, Gandhi Nagar, Bhopal 462036, MP, India
| | - Piyush Trivedi
- School of Pharmaceutical Sciences, Rajiv Gandhi Technical University, Airport Bypass Road, Gandhi Nagar, Bhopal 462036, MP, India
| |
Collapse
|
10
|
|